Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
144M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
43M
-
Shares change
-
+11.5M
-
Total reported value, excl. options
-
$107M
-
Value change
-
+$29.1M
-
Put/Call ratio
-
0
-
Number of buys
-
34
-
Number of sells
-
-13
-
Price
-
$2.49
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q3 2023
65 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q3 2023.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43M shares
of 144M outstanding shares and own 29.91% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (7.95M shares), VR Adviser, LLC (5.66M shares), Knoll Capital Management, LLC (5.16M shares), Alyeska Investment Group, L.P. (4.22M shares), ARMISTICE CAPITAL, LLC (3.4M shares), FMR LLC (2.64M shares), Simplify Asset Management Inc. (2.42M shares), Parkman Healthcare Partners LLC (1.75M shares), VANGUARD GROUP INC (1.43M shares), and Soleus Capital Management, L.P. (1.19M shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.